Genitourinary Cancer

Genitourinary Cancer News & Features

Conferring with a patient about treatment.

Screening for Frailty May Improve Outcomes for Older Patients With Genitourinary Malignancies

February 19, 2020

The VES-13, a brief frailty screening tool, was found effective in determining which older patients with GU cancer were at higher risk for adverse outcomes and would benefit from a CGA.

A nurse comforts a patient with advanced cancer.

Use of Palliative Care in Managing Genitourinary Malignancies May Vary Across the United States

John Schieszer

February 19, 2020

Patients with GU malignancies were more likely to receive palliative care if they were in the West compared with other US regions.

Novel Bladder Cancer Salvage Therapy Appears Safe, Effective

Jody A. Charnow, Editor

February 18, 2020

Nadofaragene firadenovec, a novel gene-mediated therapy, achieved a 53.4% complete response rate in patients with high-grade carcinoma in situ unresponsive to bacillus Calmette-Guérin, phase 3 trial results show.

Bladder Cancer Surgery Safe Following Neoadjuvant Immunotherapy

Jody A. Charnow

January 21, 2020

Toxicity profile and readmission rates among patients who underwent radical cystectomy and pelvic lymph node dissection following neoadjuvant pembrolizumab are in line with previously published series reporting 90-day outcomes after RC with or without neoadjuvant chemotherapy.

Pembrolizumab Approved for BCG-Unresponsive, High-Risk Non-Muscle Invasive Bladder Cancer

Diana Ernst, RPh

January 16, 2020

The Food and Drug Administration (FDA) has approved Keytruda (pembrolizumab; Merck) for the treatment of patients with Bacillus Calmette-Guerin (BCG)-unresponsive, high-risk, non-muscle invasive bladder cancer with carcinoma in situ (CIS) with or without papillary tumors who are ineligible for or have elected not to undergo cystectomy.

Clinical Trial: Prospective Randomised Phase II Trial Evaluating Adjuvant Pelvic Radiotherapy Using Either IMRT or 3-Dimensional Planning for Endometrial Cancer

Next post in Genitourinary Cancer

Genitourinary Cancer

Screening for Frailty May Improve Outcomes for Older Patients With Genitourinary Malignancies

Use of Palliative Care in Managing Genitourinary Malignancies May Vary Across the United States

Novel Bladder Cancer Salvage Therapy Appears Safe, Effective

Bladder Cancer Surgery Safe Following Neoadjuvant Immunotherapy

Pembrolizumab Approved for BCG-Unresponsive, High-Risk Non-Muscle Invasive Bladder Cancer

Genitourinary Cancer Clinical Trials

Clinical Trial: Intraoperative Monitoring of the Pelvic Autonomic Nerves (NEUROS)

Clinical Trial: Integrated Molecular Profiling in Advanced Cancers Trial (IMPACT)

Clinical Trial: Maternal Genitourinary Infections and Adverse Perinatal Outcomes

Clinical Trial: Inflammatory Response and Tissue Fibrosis/ Lymphatico-venous Bypass

Clinical Trial: Prospective Randomised Phase II Trial Evaluating Adjuvant Pelvic Radiotherapy Using Either IMRT or 3-Dimensional Planning for Endometrial Cancer

Want to read more?

Use of Palliative Care in Managing Genitourinary Malignancies May Vary Across the United States